Pharma Centrum Nowoczesnych Technologiisp. z o.o.
Other activities auxiliary to financial services, except insurance and pension funding
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2010-01-14
Share capital
250,000.00 PLN
Registered address
ul. Fasolowa 20A, 02-482 Warszawa, Poland
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $1,093 |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 93 days late).
- 202512/07/2026
- 202410/07/2025
- 202314/07/2024
- 202215/07/2023
- 202116/10/2022
- 202012/07/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 57.70kMedianUSD 74.96kAverageUSD 3.17m
Net profit
This companyUSD 6.69kMedianUSD 3.50kAverageUSD 264.65k
Operating costs
This companyUSD 49.91kMedianUSD 60.65kAverageUSD 2.40m
Assets
This companyUSD 36.79kMedianUSD 65.96kAverageUSD 5.84m
Industry
Authorized Representatives
Piotr Artur Kusy – Vice President of the Management Board
Rafał Grzegorz Kusy – President of the Management Board
Manner of representation
Each member of the management board has the right to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Piotr Artur Kusyage 64 | 125 | $33,765.53 | 50% |
Rafał Grzegorz Kusyage 54 | 125 | $33,765.53 | 50% |
Piotr Artur Kusy and Rafał Grzegorz Kusy hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Rapa Consultingsp. z o.o. | 13,506.21 USD | 100% | ||
Technovellasp. z o.o. | 11,885.47 USD | 88% |
Bank accounts
Registered as a VAT taxpayer on 2015-05-14.
52 1020 1097 0000 7602 0275 8217
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 4, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $615$615 | Polski Fundusz Rozwoju S.A. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Kancelaria Bankowasp. z o.o. | $83,333.17 | kancelariabankowa.pl | ||
| Kancelaria Doradztwa Gospodarczego XelexS.K.A. | $81,475.75 | xelex.pl | ||
| DGTL Financesp. z o.o. | $78,337.44 | dgtl.finance | ||
| NetpowerS.A. | $77,281.27 | icmpoland.com | ||
| Money4yousp. z o.o. | $65,493.93 | money4you.com.pl | ||
| Finance 4 Prosp. z o.o. | $58,748.43 | finance4pro.pl | ||
| Finaidsp. z o.o. | $49,322.60 | finaid.pl | ||
| Trufinansesp. z o.o. | $43,310.00 | trufinanse.pl | ||
| Rock Solid Investmentssp. z o.o. | $34,504.83 | rocksolidinvestments.pl | ||
| Startbusiness.Plsp. z o.o. | $27,319.36 | startbusiness.pl |
Change history
| Date | Event | |
|---|---|---|
| 2016-01-15 | Address change (Ks. Wawrzyniaka 1, 62-052, Komorniki → Ul. Fasolowa 20a, 02-482, Warszawa) | |
| 2016-01-15 | Name change (Esa Trucks Świecko → Pharma Centrum Nowoczesnych Technologii) | |
| 2016-01-15 | PKD change (Removed: 8 codes; Added: 8 codes) | |
| 2015-01-22 | PKD change (Removed: 20 codes) | |
| 2014-02-20 | Address change (Wójtowska 12, 64-654, Poznań → Ks. Wawrzyniaka 1, 62-052, Komorniki) |
FAQ
The main business activity of Pharma Centrum Nowoczesnych Technologii focuses on other activities auxiliary to financial services.
The company was registered in the Polish National Court Register (KRS) on January 14, 2010.
The headquarters is located at: ul. Fasolowa 20A, 02-482 Warszawa.
The share capital of the company is PLN 250,000 (approx. $67,531).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $52,532, representing an increase of 56.4% compared to 2023.
Yes, in 2024 the company was profitable, achieving a net profit of $14,473, meaning the company increased its profit by 44.1%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $18,667 in 2024, representing 51% of all operating expenses.
Last updated: 2026-07-16